Literature DB >> 17544085

Adrenalectomy in Veterans Affairs and selected university medical centers: results of the patient safety in surgery study.

Florence E Turrentine1, William G Henderson, Shukri F Khuri, Tracy L Schifftner, William B Inabnet, Mahmoud El-Tamer, C Joseph Northup, Virginia B Simpson, Leigh Neumayer, John B Hanks.   

Abstract

BACKGROUND: Data from the Patient Safety in Surgery Study were used to compare preoperative risk factors, intraoperative variables, and surgical outcomes of adrenalectomy procedures performed in 81 Veterans Affairs (VA) hospitals with those performed in 14 private-sector (PS) hospitals. STUDY
DESIGN: This study is a retrospective review of prospectively collected data on all patients undergoing adrenalectomy in the VA and PS for fiscal years 2002 through 2004. Bivariate analysis compared VA and PS preoperative risk factors, intraoperative variables, and 30-day morbidity and mortality. Regression risk-adjustment analysis was used to compare 30-day postoperative morbidity in the VA and PS.
RESULTS: During the 3 years studied, 178 VA patients and 371 PS patients underwent adrenalectomy procedures with a median per site of 2 (range 1-9) and 21 (range 8-70) procedures per VA and PS hospital, respectively. The VA patients had considerably more comorbidities than PS patients. The unadjusted 30-day morbidity rate was significantly higher in VA (16.29%) than PS (6.74%) hospitals (p = 0.0003); after controlling for the higher rate of comorbidities, the adjusted odds ratio for morbidity in the VA versus the PS hospitals was no longer significant (odds ratio = 1.328; 95% CI, 0.488-3.613). Unadjusted mortality rate was VA 2.81%, PS 0.27%, p = 0.0074. The low event rate overall precluded risk adjustment for mortality.
CONCLUSIONS: The VA adrenalectomy population has more preoperative risk factors and substantially higher unadjusted 30-day postoperative morbidity and mortality rates than the PS population. After risk adjustment, there is no significant difference in morbidity between the VA and the PS. A larger study population is needed to compare risk-adjusted mortality between the VA and PS.

Entities:  

Mesh:

Year:  2007        PMID: 17544085     DOI: 10.1016/j.jamcollsurg.2007.03.014

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  7 in total

1.  Laparoscopic adrenalectomy--10-year experience at a teaching hospital.

Authors:  Sandra Sommerey; Yalda Foroghi; Costanza Chiapponi; Sebastian F Baumbach; Klaus K J Hallfeldt; Roland Ladurner; Julia K S Gallwas
Journal:  Langenbecks Arch Surg       Date:  2015-02-27       Impact factor: 3.445

2.  SAGES Guidelines for minimally invasive treatment of adrenal pathology.

Authors:  L Michael Brunt
Journal:  Surg Endosc       Date:  2013-08-31       Impact factor: 4.584

3.  Previously unreported high-grade complications of adrenalectomy.

Authors:  Deron J Tessier; Rafael Iglesias; William C Chapman; Kent Kercher; Brent D Matthews; D Lee Gorden; L Michael Brunt
Journal:  Surg Endosc       Date:  2008-04-29       Impact factor: 4.584

Review 4.  Comparing VA and Non-VA Quality of Care: A Systematic Review.

Authors:  Claire O'Hanlon; Christina Huang; Elizabeth Sloss; Rebecca Anhang Price; Peter Hussey; Carrie Farmer; Courtney Gidengil
Journal:  J Gen Intern Med       Date:  2016-07-15       Impact factor: 5.128

5.  Complications in laparoscopic adrenalectomy: the value of experience.

Authors:  Carlo Bergamini; Jacopo Martellucci; Fabiano Tozzi; Andrea Valeri
Journal:  Surg Endosc       Date:  2011-06-17       Impact factor: 4.584

6.  Laparoscopic adrenalectomy by transabdominal lateral approach: 20 years of experience.

Authors:  Thibaut Coste; Robert Caiazzo; Fanelly Torres; Marie Christine Vantyghem; Bruno Carnaille; Christine Do Cao; Claire Douillard; François Pattou
Journal:  Surg Endosc       Date:  2016-11-10       Impact factor: 4.584

7.  Predictors of complication after adrenalectomy.

Authors:  Victor Srougi; João A B Barbosa; Isaac Massaud; Isadora P Cavalcante; Fabio Y Tanno; Madson Q Almeida; Miguel Srougi; Maria C Fragoso; José L Chambô
Journal:  Int Braz J Urol       Date:  2019 May-Jun       Impact factor: 1.541

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.